Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Neutral endopeptidase and alcohol consumption, experiments in neutral endopeptidase-deficient mice

  • Wolf Eberhard Siems
  • , Bjoern Maul
  • , Winfried Krause
  • , Craig Gerard
  • , Kurt F. Hauser
  • , Louis B. Hersh
  • , Hanspeter S. Fischer
  • , Gerald Zernig
  • , Alois Saria

Producción científica: Articlerevisión exhaustiva

17 Citas (Scopus)

Resumen

Alcohol consumption was investigated in mice which were rendered deficient in the peptide-degrading enzyme neutral endopeptidase (EC 3.4.24.11) (NEP-/-) by gene targeting and compared to alcohol consumption in corresponding wild type mice (NEP+/+). Mice were offered a free choice to drink tap water or 10% alcohol. The NEP-/- mice consumed significantly more alcohol (~42%) than the NEP+/+ mice, whereas no significant differences were observed in the total fluid consumption. The daily food consumption of alcohol naive NEP-/- animals was elevated (~29%). Furthermore, the activities of peptidases closely related to neutral endopeptidase were analysed ex vivo in several brain regions from NEP-/- and NEP+/+ mice not treated with alcohol. There was no obvious compensation for the total loss of neutral endopeptidase by the functionally related peptidases angiotensin-converting enzyme and aminopeptidase N. In vitro, the degradation of exogenously applied [Leu5]enkephalin was not reduced in membrane preparations of those brain regions assayed in NEP-/- mice. A small reduction in [Leu5]enkephalin degradation was detected in striatal membrane preparations of NEP-/- mice, if aminopeptidase N was additionally blocked by bestatin or amastatin. Copyright (C) 2000 Elsevier Science B.V.

Idioma originalEnglish
Páginas (desde-hasta)327-334
Número de páginas8
PublicaciónEuropean Journal of Pharmacology
Volumen397
N.º2-3
DOI
EstadoPublished - jun 2 2000

Nota bibliográfica

Funding Information:
The authors are grateful for the excellent technical assistance of R. Lange and M. Schlender. This work was supported in part by NIH grants DA02243 to LBH and DA06204 to KFH.

Financiación

The authors are grateful for the excellent technical assistance of R. Lange and M. Schlender. This work was supported in part by NIH grants DA02243 to LBH and DA06204 to KFH.

FinanciadoresNúmero del financiador
National Institutes of Health (NIH)DA06204
National Institutes of Health (NIH)
Author National Institute on Drug Abuse DA031791 Mark J Ferris National Institute on Drug Abuse DA006634 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA026117 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA028162 Elizabeth G Pitts National Institute of General Medical Sciences GM102773 Elizabeth G Pitts Peter McManus Charitable Trust Mark J Ferris National Institute on Drug AbuseR01DA002243
Author National Institute on Drug Abuse DA031791 Mark J Ferris National Institute on Drug Abuse DA006634 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA026117 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA028162 Elizabeth G Pitts National Institute of General Medical Sciences GM102773 Elizabeth G Pitts Peter McManus Charitable Trust Mark J Ferris National Institute on Drug Abuse

    ASJC Scopus subject areas

    • Pharmacology

    Huella

    Profundice en los temas de investigación de 'Neutral endopeptidase and alcohol consumption, experiments in neutral endopeptidase-deficient mice'. En conjunto forman una huella única.

    Citar esto